Two Bills Expanding Access to Treatment Signed Into Law

Montana Gov. Steve Bullock signed HB 16. The new law, which takes effect in October, will make it easier for people with severe mental illness to get treatment by allowing an officer to initiate an emergency evaluation for a person with mental illness who appears unable to meet his or her own basic needs of clothing, shelter, food, health or safety. Currently, the law requires imminent danger of death or bodily harm before an officer can initiate an emergency evaluation. The bill was supported by a number of Montana advocates who worked tirelessly for its passage.

Meanwhile, Indiana Gov. Mike Pence signed HB 1130 into law. The bill will further empower police officers to detain and transport people with severe mental illness who appear to be gravely disabled for psychiatric evaluation. This new law will ultimately make it much easier to secure treatment for people in the midst of a crisis.

Both bills illustrate how strong the tide of reform is this year. However they are achieved, treatment law reforms save lives and family and are cause for celebration. We are celebrating these and applauding the policy makers and advocates who made them happen.

–The Treatment Advocacy Center

Full Article

See What We’ve Done So Far This Year — 2013

This year SARDAA has already hosted several successful events. Our work has inspired others to improve care and policy for individuals with schizophrenia, raise awareness, and start new Schizophrenic’s Anonymous groups. We will continue to host conferences and events to promote these goals. If you missed any of these events, check out what you missed (below) and consider joining us at our next event–our 2nd annual conference in Houston, TX on October 26, 2013.

January: NIMH Research Alliance Partner’s Meeting

March: Presentation for the West Houston Health and Wellness Committee

Exhibit at Family 2 Family Conference

NIMH Outreach Partner’s meeting and exhibit.

April: National Council Mental Health and Addictions Conference–Dr. Fredrick Frese, nominated by SARDAA, won the Lilly Reintegration Award for Advocacy.

Dr. Fred Frese and Linda Stalters

Presented Webinar in partnership with John Hopkins Medicine on PsychiatryCareLive

Houston NAMI GC Walk boothLinda Stalters at NAMI Walk booth

May: Exhibit at Katy ISD

Presentation for Family Services of Greater Houston

Cocktails and Couture–SARDAA’s 5th Anniversary Celebration and Schizophrenia Awareness Recognition

Cocktails and Couture Event poster

Stay tuned to hear about our next events!

 

 

The Nose Knows Schizophrenia

Collecting tissue samples from the nose during a simple biopsy may lead to better diagnosis of schizophrenia, new research suggests.

A small study showed that all 7 of the initial participants with schizophrenia had significantly elevated microRNA (miRNA) expression in their olfactory cells compared with the 7 participants who did not have the disorder.

Further analysis of samples captured by laser microdissecion from a cohort of 36 participants showed that the same elevated brain-enriched expression in miR-382 was found in those with schizophrenia vs those without.

“The take-home message for clinicians is that molecular markers are terrific potential candidates for complex disorders, such as those involving psychiatric symptoms,” senior author Noam Shomron, PhD, from the Department of Cell and Developmental Biology at Tel Aviv University in Israel, told Medscape Medical News.

“Further research is needed to substantiate our findings and to pinpoint whether our markers are cause or causative in this disease,” added Dr. Shomron.

Still, the investigators note that the results illustrate “the potential utility” of tissues and cells from the olfactory epithelium (OE) “as surrogate samples for the brain.”

by Deborah Brauser, Medscape

Full Article

Photos: Dr. Fred Frese, Nominated by SARDAA, Won Reintegration Award for Advocacy

Dr. Fred Frese
Dr. Fred Frese

SARDAA was proud and honored to nominate Dr Fredrick Frese, the winner of the Lilly Reintegration Award for Advocacy.

On April 9, 2013, during the 43rd National Council Mental Health and Addictions Conference, the National Council for Community Behavioral Healthcare hosted it’s Celebration of Excellence in Las Vegas, NV. This celebration honors distinguished behavioral healthcare individuals and organizations that have set themselves apart with the Awards of Excellence — the most prestigious awards in behavioral healthcare. In 2013, the National Council is proud to partner with Eli Lilly and Company to include the Reintegration Awards and Welcome Back Awards in the Awards of Excellence celebration.

Since 1997, the Reintegration Awards, supported by Eli Lilly and Company, have celebrated the achievements of those in the community who dedicate themselves to improving the lives of individuals with serious mental illnesses, and the achievements of those living with schizophrenia or bipolar disorder who battle tremendous odds to improve their own lives and the lives of their peers.

Each of the winners receive grants to donate to a nonprofit of their choice as a part of their awardSchizophrenia and Related Disorders Alliance of America, was designated by the Fred Frese, PhD, winner of the Reintegration Award for Advocacy, to receive a donation in honor of the work you do.

Linda, Fred, Peggy
Linda, Fred, Peggy
Fred Frese Award
Fred Frese Award
Linda Stalters and Dr. Fred Frese
Linda Stalters and Dr. Fred Frese